Recent Posts
- Azalea Therapeutics Presents New Preclinical Data Demonstrating Robust In Vivo Generation of TRAC-CAR T Cells Using Enveloped Delivery Vehicles (EDVs)
- Jennifer Doudna spinoff aims to turn patients’ immune cells into CAR-T fighters with single shot
- Jennifer Doudna startup launches with $82M to apply new CRISPR delivery technology to in vivo CAR-T
- New in vivo gene editing biotech blossoms from CRISPR pioneer Jennifer Doudna’s lab with $82M
- Why Jennifer Doudna, Reed Jobs and others are backing this East Bay biotech’s in-body cell fix-it shop
Recent Comments
No comments to show.

